Bank Julius Baer & Co’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$9K 686
2021
Q4
$9K Buy
+200
New +$12K ﹤0.01% 788

Other funds holding NBP

Bank Julius Baer & Co's NBP Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2022, closing a stake of 200 shares — an estimated $9K sold.

Bank Julius Baer & Co first reported a position in NBP in Q4 2021 and held it in 1 quarter. The position peaked at $9K in Q4 2021. 120 funds tracked by Wall St. Rank hold NBP as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 200 NovaBridge Biosciences American Depositary Shares shares in Q1 2022, an estimated $9K.
  • Bank Julius Baer & Co first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2021 and held it in 1 quarter.
  • Bank Julius Baer & Co's NovaBridge Biosciences American Depositary Shares position peaked at $9K in Q4 2021.
  • 120 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.